Bookbot

The Vaccine

Autores

Valoración del libro

Parámetros

  • 272 páginas
  • 10 horas de lectura

Más información sobre el libro

"In mid-January 2020, Ugur Sahin told èOzlem Tèureci, his wife and decades-long research partner, that a vaccine against what would soon be known as COVID-19 could be developed and safely injected into the arms of millions before the end of the year ... While working to revolutionize the way that cancerous tumors are treated, the couple had explored a volatile and overlooked molecule called messenger RNA; they believed it could be harnessed to redirect the immune system's forces against any number of diseases. As the founders of BioNTech, they faced widespread skepticism from the scientific community at first; but by the time Sars-Cov-2 was discovered in Wuhan, China, BioNTech was prepared to deploy cutting edge technology and create the world's first clinically approved inoculation for the coronavirus"--

Compra de libros

The Vaccine, Joe Miller

Idioma
Publicado en
2022
product-detail.submit-box.info.binding
(Tapa dura)
Te avisaremos por correo electrónico en cuanto lo localicemos.

Métodos de pago

4,3
Muy bueno
335 Valoraciones

Nos falta tu reseña aquí

Idioma
Inglés
Autores
Joe Miller
Publicado en
2022
Formato
Tapa dura
Páginas
272
ISBN10
1250280362
ISBN13
9781250280367
Serie
Calificación
4,25 de 5
Descripción
"In mid-January 2020, Ugur Sahin told èOzlem Tèureci, his wife and decades-long research partner, that a vaccine against what would soon be known as COVID-19 could be developed and safely injected into the arms of millions before the end of the year ... While working to revolutionize the way that cancerous tumors are treated, the couple had explored a volatile and overlooked molecule called messenger RNA; they believed it could be harnessed to redirect the immune system's forces against any number of diseases. As the founders of BioNTech, they faced widespread skepticism from the scientific community at first; but by the time Sars-Cov-2 was discovered in Wuhan, China, BioNTech was prepared to deploy cutting edge technology and create the world's first clinically approved inoculation for the coronavirus"--